Recent 13F filings as of September 2025 show that 131 institutional investors hold a position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BVF INC/IL | 30 Sep, 2025 | 4,629,289 | 0 | 0.00% | $40,228,521.00 |
| RA CAPITAL MANAGEMENT, L.P. | 30 Sep, 2025 | 4,563,211 | 0 | 0.00% | $39,654,304.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 4,128,416 | -30,848 | -0.74% | $35,875,935.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 3,869,130 | -141,625 | -3.53% | $33,622,738.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 2,575,122 | -161,549 | -5.90% | $22,377,810.00 |
| Novo Holdings A/S | 30 Sep, 2025 | 2,000,000 | 0 | 0.00% | $17,380,000.00 |
| JANUS HENDERSON GROUP PLC | 30 Sep, 2025 | 1,753,367 | -1,043 | -0.06% | $15,236,691.00 |
| FEDERATED HERMES, INC. | 30 Sep, 2025 | 1,594,832 | -72,506 | -4.35% | $13,859,090.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 1,149,401 | -334,323 | -22.53% | $9,988,295.00 |
| ARMISTICE CAPITAL, LLC | 30 Sep, 2025 | 1,096,000 | 796,000 | 265.33% | $9,524,240.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 913,519 | -5,014 | -0.55% | $7,940,280.00 |
| STATE STREET CORP | 30 Sep, 2025 | 903,774 | -58,188 | -6.05% | $7,853,796.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 835,911 | -88,765 | -9.60% | $7,264,066.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 819,266 | -77,804 | -8.67% | $7,119,421.00 |
| Assenagon Asset Management S.A. | 30 Sep, 2025 | 663,657 | 14,832 | 2.29% | $5,767,179.00 |
| TWO SIGMA ADVISERS, LP | 30 Sep, 2025 | 549,700 | -193,700 | -26.06% | $4,776,893.00 |
| DEUTSCHE BANK AG\ | 30 Sep, 2025 | 543,331 | 316,392 | 139.42% | $4,721,546.00 |
| JPMORGAN CHASE & CO | 30 Sep, 2025 | 513,515 | -374,501 | -42.17% | $4,462,445.00 |
| ArrowMark Colorado Holdings LLC | 30 Sep, 2025 | 504,115 | -10,499 | -2.04% | $4,380,759.00 |
| RAYMOND JAMES FINANCIAL INC | 30 Sep, 2025 | 471,270 | 15,800 | 3.47% | $4,095,336.00 |